| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman And CMO
1 company
Kim Christopher serves as a Chairman And CMO at APUS. Across recent SEC filings that breaks down to 2 buys and 0 sells. Those positions are worth an estimated $1.3M at current prices.
The biggest single holding is APUS (~$1.3M) as Chairman And CMO. Net of sales, the recent Form 4 record there shows accumulation of 27,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2025 | APUS Apimeds Pharmaceuticals Us, Inc. | Chairman And CMO | Buy | 27,500 | $1.83 | $50,359.20 | +139.1% | -13.4% | -26.3% |